Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer.
about
High circulating activin A level is associated with tumor progression and predicts poor prognosis in lung adenocarcinoma.High serum haptoglobin level is associated with tumor progression and predicts poor prognosis in non-small cell lung cancer.Early2 factor (E2F) deregulation is a prognostic and predictive biomarker in lung adenocarcinoma.A functional polymorphism in lnc-LAMC2-1:1 confers risk of colorectal cancer by affecting miRNA binding.Elevated serum LAMC2 is associated with lymph node metastasis and predicts poor prognosis in penile squamous cell carcinoma
P2860
Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Serum LAMC2 enhances the progn ...... in non-small cell lung cancer.
@ast
Serum LAMC2 enhances the progn ...... in non-small cell lung cancer.
@en
type
label
Serum LAMC2 enhances the progn ...... in non-small cell lung cancer.
@ast
Serum LAMC2 enhances the progn ...... in non-small cell lung cancer.
@en
prefLabel
Serum LAMC2 enhances the progn ...... in non-small cell lung cancer.
@ast
Serum LAMC2 enhances the progn ...... in non-small cell lung cancer.
@en
P2093
P2860
P356
P1476
Serum LAMC2 enhances the progn ...... in non-small cell lung cancer
@en
P2093
A Dimitromanolakis
D Korbakis
E P Diamandis
P2860
P2888
P304
P356
10.1038/BJC.2015.171
P407
P577
2015-07-16T00:00:00Z